The Tie2-agonist vasculotide rescues mice from influenza virus infection

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Sugiyama, Michael G ^a,b   Armstrong, Susan M ^a   Wang, Changsen ^a   Hwang, David ^b,c   Leong Poi, Howard ^a   Advani, Andrew ^a   Advani, Suzanne ^a   Zhang, Haibo ^a   Szaszi, Katalin ^a   Tabuchi, Arata ^a   Kuebler, Wolfgang M ^a   Van Slyke, Paul ^d   Dumont, Dan J ^d   Lee, Warren L ^a,b  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d Canada   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPOIETIN RECEPTOR; PEPTIDE; TEK PROTEIN, MOUSE;

AGONISTS; ANIMAL; BRONCHOALVEOLAR LAVAGE FLUID; C57BL MOUSE; CELL CULTURE; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; ENDOTHELIUM CELL; HUMAN; IMMUNOLOGY; INFLUENZA A VIRUS (H1N1); INFLUENZA A VIRUS (H3N2); METABOLISM; MORTALITY; MOUSE; NEUTROPHIL; ORTHOMYXOVIRIDAE INFECTIONS; PATHOLOGY; PHYSIOLOGY; SURVIVAL RATE; VIRUS REPLICATION;

ANIMALS; BRONCHOALVEOLAR LAVAGE FLUID; CELLS, CULTURED; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; MICE; MICE, INBRED C57BL; NEUTROPHILS; ORTHOMYXOVIRIDAE INFECTIONS; PEPTIDES; RECEPTOR, TIE-2; SURVIVAL RATE; VIRUS REPLICATION;

EID: 84930933758     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep11030     Document Type: Article

References (44)

1. Shirey, K. A. et al. The TLR4 antagonist Eritoran protects mice from lethal influenza infection. Nature 497, 498-502.
2. Thompson, W. W. et al. Mortality associated with influenza and respiratory syncytial virus in the United States. Jama 289, 179-186 (2003).
3. Taubenberger, J. K. & Morens, D. M. The pathology of influenza virus infections. Annu Rev Pathol 3, 499-522 (2008).
4. McGeer, A. et al. Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada. Clin Infect Dis 45, 1568-1575 (2007).
5. Jefferson, T. et al. Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. Cochrane Database Syst Rev 4, CD008965.
6. Baranovich, T. et al. The neuraminidase inhibitor oseltamivir is effective against A/Anhui/1/2013 (H7N9) influenza virus in a mouse model of acute respiratory distress syndrome. J Infect Dis 209, 1343-1353.
7. Ng, S. et al. Effects of oseltamivir treatment on duration of clinical illness and viral shedding and household transmission of influenza virus. Clin Infect Dis 50, 707-714 (2010).
8. Sleeman, K. et al. Antiviral susceptibility of variant influenza A(H3N2)v viruses isolated in the United States from 2011 to 2013. Antimicrob Agents Chemother 58, 2045-2051 (2014).
9. Kelso, A. & Hurt, A. C. The ongoing battle against influenza: Drug-resistant influenza viruses: why fitness matters. Nat Med 18, 1470-1471 (2012).
10. Dominguez-Cherit, G. et al. Critically Ill patients with 2009 influenza A(H1N1) in Mexico. Jama 302, 1880-1887 (2009).
11. Louria, D. B., Blumenfeld, H. L., Ellis, J. T., Kilbourne, E. D. & Rogers, D. E. Studies on influenza in the pandemic of 1957-1958. II. Pulmonary complications of influenza. J Clin Invest 38, 213-265 (1959).
12. Lee, W. L. & Slutsky, A. S. Ventilator-induced lung injury and recommendations for mechanical ventilation of patients with ARDS. Semin Respir Crit Care Med 22, 269-280 (2001).
13. Matthay, M. A., Ware, L. B. & Zimmerman, G. A. The acute respiratory distress syndrome. J Clin Invest 122, 2731-2740 (2012).
14. London, N. R. et al. Targeting Robo4-dependent slit signaling to survive the cytokine storm in sepsis and influenza. Sci Transl Med 2, 23ra19 (2010).
15. Narasaraju, T. et al. Excessive neutrophils and neutrophil extracellular traps contribute to acute lung injury of influenza pneumonitis. Am J Pathol 179, 199-210 (2011).
16. David, S. et al. Effects of a synthetic PEG-ylated Tie-2 agonist peptide on endotoxemic lung injury and mortality. Am J Physiol Lung Cell Mol Physiol 300, L851-862 (2011).
17. Tate, M. D. et al. The role of neutrophils during mild and severe influenza virus infections of mice. PLoS One 6, e17618 (2011).
18. Nguyen, J. T. et al. Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses. PLoS One 7, e31006 (2012).
19. Davis, S. et al. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell 87, 1161-1169 (1996).
20. Kugathasan, L. et al. The angiopietin-1-Tie2 pathway prevents rather than promotes pulmonary arterial hypertension in transgenic mice. J Exp Med 206, 2221-2234 (2009).
21. Wong, A. L. et al. Tie2 expression and phosphorylation in angiogenic and quiescent adult tissues. Circ Res 81, 567-574 (1997).
22. DeBusk, L. M., Hallahan, D. E. & Lin, P. C. Akt is a major angiogenic mediator downstream of the Ang1/Tie2 signaling pathway. Exp Cell Res 298, 167-177 (2004).
23. Petri, B. et al. Endothelial LSP1 is involved in endothelial dome formation, minimizing vascular permeability changes during neutrophil transmigration in vivo. Blood 117, 942-952 (2011).
24. David, S., Kumpers, P., van Slyke, P. & Parikh, S. M. Mending leaky blood vessels: the angiopoietin-Tie2 pathway in sepsis. J Pharmacol Exp Ther 345, 2-6 (2013).
25. Thurston, G. et al. Angiopoietin-1 protects the adult vasculature against plasma leakage. Nat Med 6, 460-463 (2000).
26. Witzenbichler, B., Westermann, D., Knueppel, S., Schultheiss, H. P. & Tschope, C. Protective role of angiopoietin-1 in endotoxic shock. Circulation 111, 97-105 (2005).
27. Koh, G. Y. Orchestral actions of angiopoietin-1 in vascular regeneration. Trends Mol Med 19, 31-39 (2013).
28. Van Slyke, P. et al. Acceleration of diabetic wound healing by an angiopoietin peptide mimetic. Tissue engineering. Part A 15, 1269-1280 (2009).
29. Tournaire, R. et al. A short synthetic peptide inhibits signal transduction, migration and angiogenesis mediated by Tie2 receptor. EMBO Rep 5, 262-267 (2004).
30. Brindle, N. P., Saharinen, P. & Alitalo, K. Signaling and functions of angiopoietin-1 in vascular protection. Circ Res 98, 1014-1023 (2006).
31. Papapetropoulos, A. et al. Angiopoietin-1 inhibits endothelial cell apoptosis via the Akt/survivin pathway. J Biol Chem 275, 9102-9105 (2000).
32. Parikh, S. M. et al. Excess circulating angiopoietin-2 may contribute to pulmonary vascular leak in sepsis in humans. PLoS Med 3, e46 (2006).
33. Hayashi, M. et al. VE-PTP regulates VEGFR2 activity in stalk cells to establish endothelial cell polarity and lumen formation. Nat Commun 4, 1672 (2013).
34. Morens, D. M., Taubenberger, J. K. & Fauci, A. S. Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis 198, 962-970 (2008).
35. Steinberg, B. E., Goldenberg, N. M. & Lee, W. L. Do viral infections mimic bacterial sepsis? The role of microvascular permeability: A review of mechanisms and methods. Antiviral Res 93, 2-15 (2012).
36. Grauslund, M. et al. A mouse model for studying the interaction of bisdioxopiperazines with topoisomerase IIalpha in vivo. Mol Pharmacol 72, 1003-1014 (2007).
37. Szretter, K. J., Balish, A. L. & Katz, J. M. Influenza: propagation, quantification, and storage. Curr Protoc Microbiol Chapter 15, Unit 15G 11 (2006).
38. Darwish, I. et al. Mesenchymal stromal (stem) cell therapy fails to improve outcomes in experimental severe influenza. PLoS One 8, e71761 (2013).
39. Armstrong, S. M. et al. Influenza infects lung microvascular endothelium leading to microvascular leak: role of apoptosis and claudin-5. PLoS One 7, e47323 (2012).
40. Tsoporis, J. T., Izhar, S., Desjardins, J. F., Leong-Poi, H. & Parker, T. G. Conditional cardiac overexpression of S100A6 attenuates myocyte hypertrophy and apoptosis following myocardial infarction. Curr Pharm Des 20, 1941-1949 (2014).
41. Matute-Bello, G. et al. An official American Thoracic Society workshop report: features and measurements of experimental acute lung injury in animals. Am J Respir Cell Mol Biol 44, 725-738 (2011).
42. Advani, A. et al. The (Pro)renin receptor: site-specific and functional linkage to the vacuolar H+ -ATPase in the kidney. Hypertension 54, 261-269 (2009).
43. Oh, H., Siano, B. & Diamond, S. Neutrophil isolation protocol. J Vis Exp (2008).
44. Armstrong, S. M. et al. Co-regulation of transcellular and paracellular leak across microvascular endothelium by dynamin and Rac. Am J Pathol 180, 1308-1323 (2012).